March 9 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] has recorded a consolidated net profit of 13.1 million euro ($14.7 million) in 2022, slightly up from 13 million euro in the previous year, it said on Thursday.
Consolidated net sales revenue grew by an annual 8.2% to 495.7 million euro in 2022, Salus said in a filing with the Ljubljana Stock Exchange.
The company's operating profit rose to 16.0 million euro from 15.3 million euro, while earnings before interest, taxes, depreciation and amortisation (EBITDA) grew to 20.5 million euro from 19.7 million euro, Salus said.
Its shares traded flat at 1,400 euro by 0952 CET on Thursday on the Ljubljana Stock Exchange.
Ljubljana-based Salus is one of Slovenia's leading wholesalers of pharmaceutical and medical products.
($ = 0.94847 euro)